Viewing Study NCT01521533

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:56 AM
Ignite Modification Date: 2025-12-31 @ 2:25 AM
Study NCT ID: NCT01521533
Status: COMPLETED
Last Update Posted: 2015-10-06
First Post: 2012-01-26
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: NOX-A12 in Combination With Bortezomib and Dexamethasone in Relapsed Multiple Myeloma
Sponsor: TME Pharma AG
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsed Multiple Myeloma View
None NOX-A12 View
None Velcade View
None Dexamethasone View
None Spiegelmer View
None Chemosensitization View
None Stromal cell-derived factor-1 (SDF-1) View
None CXCL12 View